Fundamentals of HIV Medicine 2021
CME Edition

Author:

Language: English
Cover of the book Fundamentals of HIV Medicine 2021

Subjects for Fundamentals of HIV Medicine 2021

143,18 €

Disponible chez l'éditeur (délai d'approvisionnement : 21 jours).

Add to cartAdd to cart
Publication date:
568 p. · 27.7x21.3 cm · Broché
The essential work in HIV for providers and pharmacists, updated for 2021. Includes CME access code for 2021 AAHIVS, AAHIVP, or AAHIVE study materials and accreditation! An end-to-end clinical resource for the treatment of individuals with HIV/AIDS, Fundamentals of HIV Medicine has served as a key resource for clinicians preventing and treating HIV for over a decade. Now updated for 2021, Fundamentals of HIV Medicine 2021 offers state-of-the-art continuing education for physicians, pharmacists, nurse practitioners, nurses, and other professionals working in the care of HIV patients. With this volume, practitioners will have immediate, indexed access to the most updated science, research, and guidelines related to all aspects of HIV care and prevention. This revised edition features key clinical updates across classic domains of HIV medicine along with recent research in HIV medicine including HIV workforce strains and PrEP, newly emerging antiretroviral treatment options, and the evolving effects of COVID-19 on HIV care. Embodying the American Academy of HIV Medicine's commitment to excellence in the care of seropositive patients, Fundamentals of HIV Medicine 2021 is a must-have for health professionals across HIV care, treatment, and prevention. Note: This edition includes a login for online CME questions and accreditation
About the Editor in Chief: W. David Hardy, MD, currently serves as Adjunct Professor of Medicine at Johns Hopkins University School of Medicine and lives in Washington, D.C. His previous professional experience includes serving as Senior Director of Research at Whitman-Walker Health in D.C. (2015-2018), Chief Medical Officer of Calimmune, a translational science company investigating gene-modified cellular therapies as a potential cure for HIV (2013-2015) and Director of the Division of Infectious Diseases at Cedars-Sinai Medical Center and Professor of Medicine at the David Geffen School of Medicine at UCLA (2002-2013). Early in the AIDS epidemic, he completed a clinical fellowship in infectious diseases/immunology and clinical research at the UCLA School of Medicine under the direction of Dr. Michael Gottlieb, the physician who recognized and reported the first cases of AIDS. Later he also completed a laboratory fellowship in molecular retrovirology with Irvin Chen at UCLA. Dr. Hardy has cared for persons with HIV infection since 1982 and conducted research on HIV and related diseases since 1984. Dr. Hardy currently serves as Chair of the Board of Directors of the HIV Medicine Association (HIVMA) and Chair of the Education Committee of the American Academy of HIV Medicine (AAHIVM). He has worked with several community-based organizations, including AIDS Research Alliance, Alliance for Housing and Healing, Being Alive-Empowering People with HIV/AIDS, Project Angel Food, and AIDS Project Los Angeles. About the American Academy of HIV Medicine (AAHIVM): The American Academy of HIV Medicine is a professional organization that supports HIV practitioners and promotes accessible, quality care for all Americans living with HIV disease. The AAHIVM membership of HIV practitioners and credentialed providers give direct care to the majority of HIV patients in the US. The Academy's HIV-focused professional certifications are the first and only credentials offered domestically